Tag Archives: discussion

FDA Starts A Discussion About How To Regulate Artificial Intelligence / Machine Learning Software As A Medical Device

By Jeffrey K. Shapiro — A cutting-edge aspect of digital health is software as a medical device (SaMD) that uses artificial intelligence and machine learning to improve its performance based on real world use and experience.  Until earlier this week, … Continue reading

Posted in Products Liability | Tagged , , , , , , , , , , | Leave a comment

Presentation: “Alexa, What Medication Am I Taking?” A discussion of privacy, security and practical issues implicated by the use of voice technology in healthcare.

Partner Colin Zick and Associate Jeremy Meisinger presented to the Massachusetts Health Information Management Association on the legal issues presented by the continued development of voice technology in healthcare.  Click here to download the slides. More Read more detail on … Continue reading

Posted in Technology & Cyberlaw | Tagged , , , , , , , , , , , , | Leave a comment

CCPA Prompts National Discussion on Future of Data Privacy Regulation

Will the California Consumer Privacy Act serve as a blueprint for a federal privacy law or for a patchwork quilt of state privacy laws? As states have been commencing legislative proceedings and as proposals for a federal privacy law are … Continue reading

Posted in Business law | Tagged , , , , , , , | Leave a comment

Washington College of Law Post-Argument Discussion of Return Mail Inc. v. United States Postal Service

As part of its ongoing Supreme Court series, the American University Washington College of Law Program on Information Justice & Intellectual Property will be hosting a post-argument discussion on the Return Mail Inc. v. United States Postal Service case from … Continue reading

Posted in Intellectual Property | Tagged , , , , , , , , , , | Leave a comment

Congress Floats Discussion Draft of IVD Legislation

By Allyson B. Mullen & Jeffrey N. Gibbs — Since FDA announced in late 2016 that it would not finalize its laboratory developed test (LDT) guidances, it has become clear that any change to the LDT regulatory framework (at least … Continue reading

Posted in Products Liability | Tagged , , , , | Leave a comment